证券记录 · 已归档季度
CAPR
Capricor Therapeutics, Inc. · Healthcare · Biotechnology
17被追踪持有人
+3Δ持有人
9.08M持有股份
$65.46M报告持仓市值
+3新建仓位
−0清仓
动量输入（同类管理人）：
持有人广度 +21.4% ·
股份流向 -3.6% ·
净新建仓位 +17.6%
— 公式
持股分散化 — 持有人增多，合计持仓比例缩小
所有持股数据：仅限已追踪的 13F 管理人，普通股持仓，报告期 Q3 2025
持股变化趋势
| 季度 | 持有人 | Δ | 股份 | 报告持仓市值 | 新增 | 清仓 |
|---|---|---|---|---|---|---|
| Q2 2026 | 70 | -1 | 21.29M | $513.07M | +4 | −5 |
| Q1 2026 | 74 | +11 | 17.90M | $543.13M | +17 | −6 |
| Q4 2025 | 63 | 0 | 16.01M | $462.15M | +1 | −1 |
| Q3 2025 | 17 | +3 | 9.08M | $65.46M | +3 | — |
| Q2 2025 | 11 | +1 | 8.31M | $82.57M | +2 | −1 |
| Q1 2025 | 7 | -3 | 3.63M | $34.48M | — | −3 |
| Q4 2024 | 10 | +4 | 3.77M | $51.99M | +5 | −1 |
| Q3 2024 | 5 | -1 | 1.06M | $16.12M | +2 | −3 |
| Q2 2024 | 6 | — | 1.44M | $6.86M | — | — |
持有人 · Q3 2025
| # | 管理人 | 股份 | Δ股份 | 价值 | 其权重 | 持有 | ||
|---|---|---|---|---|---|---|---|---|
| 1 | BlackRock ✦ (被动) | 2.87M | -3.8% | $20.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 2 | BlackRock ✦ (被动) | 2.87M | -3.8% | $20.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 3 | BlackRock ✦ (被动) | 2.87M | -3.8% | $20.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 4 | BlackRock ✦ (被动) | 2.87M | -3.8% | $20.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 5 | BlackRock ✦ (被动) | 2.87M | -3.8% | $20.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 6 | BlackRock ✦ (被动) | 2.87M | -3.8% | $20.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 7 | BlackRock ✦ (被动) | 2.87M | -3.8% | $20.69M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 8 | The Vanguard Group ✦ (被动) | 2.21M | -4.3% | $15.91M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 9 | The Vanguard Group ✦ (被动) | 2.21M | -4.3% | $15.91M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 10 | The Vanguard Group ✦ (被动) | 2.21M | -4.3% | $15.91M | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 11 | Geode Capital Management ✦ (被动) | 961.57K | -0.2% | $6.93M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 12 | Geode Capital Management ✦ (被动) | 961.57K | -0.2% | $6.93M | 0.0% | ▼ Trim | 6 | SEC ↗ |
| 13 | State Street Global Advisors ✦ (被动) | 801.34K | -45.4% | $5.78M | 0.0% | ▼ Trim | 4 | SEC ↗ |
| 14 | Morgan Stanley ✦ | 551.69K | — | $3.98M | 0.0% | n/c | 1 | SEC ↗ |
| 15 | Morgan Stanley ✦ | 551.69K | — | $3.98M | 0.0% | n/c | 1 | SEC ↗ |
| 16 | Morgan Stanley ✦ | 551.69K | — | $3.98M | 0.0% | n/c | 1 | SEC ↗ |
| 17 | Morgan Stanley ✦ | 551.69K | — | $3.98M | 0.0% | n/c | 1 | SEC ↗ |
| 18 | Morgan Stanley ✦ | 551.69K | — | $3.98M | 0.0% | n/c | 1 | SEC ↗ |
| 19 | Morgan Stanley ✦ | 551.69K | — | $3.98M | 0.0% | n/c | 1 | SEC ↗ |
| 20 | JPMorgan Chase ✦ | 379.60K | — | $2.74M | 0.0% | n/c | 1 | SEC ↗ |
| 21 | JPMorgan Chase ✦ | 379.60K | — | $2.74M | 0.0% | n/c | 1 | SEC ↗ |
| 22 | JPMorgan Chase ✦ | 379.60K | — | $2.74M | 0.0% | n/c | 1 | SEC ↗ |
| 23 | JPMorgan Chase ✦ | 379.60K | — | $2.74M | 0.0% | n/c | 1 | SEC ↗ |
| 24 | JPMorgan Chase ✦ | 379.60K | — | $2.74M | 0.0% | n/c | 1 | SEC ↗ |
| 25 | JPMorgan Chase ✦ | 379.60K | — | $2.74M | 0.0% | n/c | 1 | SEC ↗ |
| 26 | JPMorgan Chase ✦ | 379.60K | — | $2.74M | 0.0% | n/c | 1 | SEC ↗ |
| 27 | JPMorgan Chase ✦ | 379.60K | — | $2.74M | 0.0% | n/c | 1 | SEC ↗ |
| 28 | Two Sigma Investments ✦ | 355.80K | +128.3% | $2.57M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 29 | Millennium Management ✦ | 202.46K | +16.5% | $1.46M | 0.0% | ▲ Add | 6 | SEC ↗ |
| 30 | Goldman Sachs Group ✦ | 175.64K | — | $1.27M | 0.0% | n/c | 1 | SEC ↗ |
| 31 | Goldman Sachs Group ✦ | 175.64K | — | $1.27M | 0.0% | n/c | 1 | SEC ↗ |
| 32 | Citadel Advisors ✦ | 150.52K | 新增 | $1.09M | 0.0% | New | 1 | SEC ↗ |
| 33 | Citadel Advisors ✦ | 150.52K | 新增 | $1.09M | 0.0% | New | 1 | SEC ↗ |
| 34 | Wellington Management ✦ | 132.31K | +0.3% | $953,992 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 35 | Wellington Management ✦ | 132.31K | +0.3% | $953,992 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 36 | Wellington Management ✦ | 132.31K | +0.3% | $953,992 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 37 | Point72 Asset Management ✦ | 118.59K | 新增 | $855,042 | 0.0% | New | 1 | SEC ↗ |
| 38 | Marshall Wace ✦ | 99.11K | +23.6% | $714,604 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 39 | Marshall Wace ✦ | 99.11K | +23.6% | $714,604 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 40 | Fidelity (FMR) ✦ | 23.69K | -2.1% | $170,801 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 41 | Fidelity (FMR) ✦ | 23.69K | -2.1% | $170,801 | 0.0% | ▼ Trim | 2 | SEC ↗ |
| 42 | T. Rowe Price ✦ | 20.57K | +8.2% | $149,000 | 0.0% | ▲ Add | 4 | SEC ↗ |
| 43 | D. E. Shaw & Co. ✦ | 15.95K | +48.6% | $114,963 | 0.0% | ▲ Add | 2 | SEC ↗ |
| 44 | AQR Capital Management ✦ | 12.36K | 新增 | $89,123 | 0.0% | New | 1 | SEC ↗ |
| 45 | AQR Capital Management ✦ | 12.36K | 新增 | $89,123 | 0.0% | New | 1 | SEC ↗ |
| 46 | AQR Capital Management ✦ | 12.36K | 新增 | $89,123 | 0.0% | New | 1 | SEC ↗ |
"持仓权重"= 该持仓占该管理人已申报13F股权价值的比例——即信念度衡量指标。✦ = 精选管理人。
新增买入方
| Citadel Advisors | $1.09M | 0.0% |
| Citadel Advisors | $1.09M | 0.0% |
| Point72 Asset Management | $855,042 | 0.0% |
| AQR Capital Management | $89,123 | 0.0% |
| AQR Capital Management | $89,123 | 0.0% |
| AQR Capital Management | $89,123 | 0.0% |
已清仓
| 本季度无被追踪的退出仓位。 |
全市场背景: 涵盖所有13F申报机构（SEC结构化数据， Q1 2026): 176 持有人, 33.48M 股份, $1.02B 已申报. 这是与上方被追踪全域数据不同的较早期间，两者从不混用。
常见共同持仓
该证券的被追踪持有人最常同时持有的其他证券——基于共同持有计数，而非基本面关联。
数据来源: 持股数据来源于已解析的13F普通股持仓（被追踪范围，变动对比集）；内部人行为来自Form 3/4/5；重大持股来自Schedule 13D/13G；所有文件均链接至SEC EDGAR原始申报。
报告期: Q3 2025 ·
方法论 ·
通过API获取此数据